Clinical Trial Update: Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of the combination of paclitaxel and everolimus for relapsed or refractory small cell lung cancer, which ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Everolimus (Afinitor) (everolimus)
• Paclitaxel (Taxol) (paclitaxel)

Snippet

Sponsor: Samsung Medical Center | Conditions: Small Cell Lung Cancer | Phase 1 | Status: COMPLETED